Loading company…
Riskpilot
← Back to search
Sign in
Get full access
LØDØEN PHARMA AS
AS
Active
Org 931639021
Enebakkveien 302, 1188 Oslo
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2023
0 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 20K
+100% vs 2024
EBITDA margin
-66.1%
+37% vs 2024
Equity ratio
-1042.6%
Financial strength
Net profit 2025
NOK -13K
+37% vs 2024
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 20K
+100%
EBITDA
NOK -13K
+37%
Net profit
NOK -13K
+37%
Total assets
NOK 752
-86%
Equity
NOK -8K
-246%
Employees
0
—
Company information
Legal name
LØDØEN PHARMA AS
Org number
931639021
Legal form
Aksjeselskap
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
29. juni 2023
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Konsulentvirksomhet og tilhørende tjenester mot apotek og legemiddelbransjen og virksomhet som herunder naturlig hører.
Contact
Address
Enebakkveien 302, 1188 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2023
2024
2025
Revenue
14
10
20
Staff expenses
−0
−0
−0
EBITDA
−3
−21
−13
Depreciation & amort.
−0
−0
−0
EBIT
−3
−21
−13
Net financials
0
0
0
Profit before tax
−3
−21
−13
Tax
−0
−0
−0
Net profit
−3
−21
−13
Balance sheet
NOK thousands
Item
2023
2024
2025
Total assets
27
5
1
Equity
27
5
−8
Long-term debt
0
0
0
Short-term debt
0
0
9
Total debt
0
0
9
Financial ratios
5-year trend
EBITDA margin
-66.1%
This company
15.8%
Market median
-518% vs market
2023
2025
Equity ratio
-1042.6%
This company
38.2%
Market median
-2829% vs market
2023
2025
Return on equity
-1322200.0%
This company
18.4%
Market median
-7185970% vs market
2023
2025
Net profit margin
-66.1%
This company
8.1%
Market median
-916% vs market
2023
2025
Asset turnover
26.60×
This company
1.12×
Market median
+2275% vs market
2023
2025
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
CP
Christine Pernille Lødøen
Deputy Chairman
2023
—
—
PB
Petter Brinch Lødøen
Chairman
2023
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of LØDØEN PHARMA AS also hold positions in
0
other companies.
Person
Role here
Other companies
Christine Pernille Lødøen
Deputy Chairman
0 companies
Petter Brinch Lødøen
Chairman
0 companies